News|Articles|June 15, 2021
Process Development Improvements Post-Pandemic
Author(s)Pharmaceutical Technology Editors
What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?
Advertisement
In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
4
The Implications of the FDA’s New Finalized Guidance Documents
5